Inventor
ZHANG BEILI
US32 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG BEILI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
26 patentsUS8846718B2Sep 30, 2014
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxo1-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA77 citations99
US9840499B2Dec 12, 2017
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA41 citations98
US9434717B2Sep 6, 2016
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA53 citations98
US9150552B2Oct 6, 2015
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA58 citations98
US8969574B2Mar 3, 2015
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
VERTEX PHARMA61 citations98
US8742122B2Jun 3, 2014
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
VERTEX PHARMA67 citations98
US9051303B2Jun 9, 2015
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-YL)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan-2-YL)-1H-indol-5-YL)-cyclopropanecarboxamide
VERTEX PHARMA59 citations97
US8802868B2Aug 12, 2014
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
VERTEX PHARMA68 citations97
US8741922B2Jun 3, 2014
Solid forms of N-(4-(7-azabicyclo[2.2,1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
VERTEX PHARMA68 citations97
US9163042B2Oct 20, 2015
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA46 citations96
US10906891B2Feb 2, 2021
Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
VERTEX PHARMA13 citations94
US10597384B2Mar 24, 2020
Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA17 citations94
US10081621B2Sep 25, 2018
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
VERTEX PHARMA29 citations94
US10787472B2Sep 29, 2020
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA12 citations93
US10570115B2Feb 25, 2020
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA23 citations93
US10253054B2Apr 9, 2019
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA17 citations93
US9828397B2Nov 28, 2017
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA23 citations93
US9464102B2Oct 11, 2016
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA23 citations92
US10654829B2May 19, 2020
Crystalline forms and compositions of CFTR modulators
VERTEX PHARMA21 citations90
US11578062B2Feb 14, 2023
Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
VERTEX PHARMA4 citations85
US11873300B2Jan 16, 2024
Crystalline forms of CFTR modulators
VERTEX PHARMA6 citations84
US11186566B2Nov 30, 2021
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA10 citations84
US11155533B2Oct 26, 2021
Crystalline forms and compositions of CFTR modulators
VERTEX PHARMA10 citations82
US12065432B2Aug 20, 2024
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
VERTEX PHARMA1 citations73
US11773119B2Oct 3, 2023
Prodrugs of pyridone amides useful as modulators of sodium channels
VERTEX PHARMA2 citations72
US12319693B2Jun 3, 2025
Crystalline forms of CFTR modulators
VERTEX PHARMA0 citations61
KESHAVARZ-SHOKRI ALI
3 patentsUS8653103B2Feb 18, 2014
Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
KESHAVARZ-SHOKRI ALI79 citations98
US8507534B2Aug 13, 2013
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
KESHAVARZ-SHOKRI ALI101 citations98
US8507687B2Aug 13, 2013
Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
KESHAVARZ-SHOKRI ALI83 citations97
ZHANG BEILI
2 patentsUS8436014B2May 7, 2013
Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
ZHANG BEILI87 citations97
US8389727B2Mar 5, 2013
Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide
ZHANG BEILI85 citations96